Toxicity of CSF in motor neurone disease: a potential route to neuroprotection

Related Experiment Video

Updated: Oct 2, 2026

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods
10:24

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

Published on: November 19, 2019

Pamela J Shaw

    Brain : a Journal of Neurology
    |March 26, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
    04:41

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

    Published on: February 24, 2026

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    Related Experiment Videos

    Last Updated: Oct 2, 2026

    Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods
    10:24

    Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

    Published on: November 19, 2019

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
    04:41

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

    Published on: February 24, 2026

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    Related Concept Videos

    Cerebrospinal Fluid01:21

    Cerebrospinal Fluid

    Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
    CSF Production
    CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
    The Blood-brain Barrier00:49

    The Blood-brain Barrier

    Overview
    Cytotoxic Edema: Pathophysiology01:21

    Cytotoxic Edema: Pathophysiology

    Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...

    Articles linked to this work by shared authors, journal, and citation graph.

    TRICALS risk score augments but cannot replace neurofilament as a prognostic biomarker in ALS.

    Journal of neurology·2026

    Adenosine Deaminase-Mediated Purine Dysfunction Leads to DNA Repair Inhibition and Senescence in Sporadic Amyotrophic Lateral Sclerosis.

    International journal of molecular sciences·2026

    Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue Donors.

    JAMA neurology·2026

    Recent developments in Friedreich's ataxia: a state-of-the-art review.

    Brain communications·2026

    hnRNPUL1 has a dead polynucleotide kinase domain that regulates RNA and protein interactions.

    iScience·2026

    The Diagnostic Potential of Axon Excitability Is Consistent Across Hand Muscles in Amyotrophic Lateral Sclerosis.

    Muscle & nerve·2026

    KCNH1 variants associated with neurodevelopmental disorders exhibit prominent gain of function.

    Brain : a journal of neurology·2026

    Global best practice recommendations for genetic counselling and testing in amyotrophic lateral sclerosis.

    Brain : a journal of neurology·2026

    Short-term outcomes, longer-term disability and relapse risk in LGI1-antibody encephalitis.

    Brain : a journal of neurology·2026

    TREM2: friend or foe in glioma?

    Brain : a journal of neurology·2026

    Do psychiatrists have a spider-sense? Clinical impressions as violations of interpersonal Bayesian expectation.

    Brain : a journal of neurology·2026

    Clinically unresponsive patients with acute brain injury activate a brain-computer interface.

    Brain : a journal of neurology·2026

    Dynamic Changes of Glu and Asp Concentrations in Blood and Spinal Fluid of Patients with Traumatic Spinal Cord Injury and Their Correlation with Prognosis.

    Journal of neurotrauma·2026

    Association between neuromuscular electrical stimulation and intermittent pneumatic compression for the prevention of deep venous thrombosis among neurosurgery patients.

    Annals of medicine·2026

    Association of Upper Trapezius Muscle Status With Pain and Disability in Patients With Chronic Nonspecific Neck Pain: A Cross-Sectional Study.

    Pain research & management·2026

    Pharmacological Modulation of HMGB1/TLR-4/NF-κB Signaling Axis in 3-Nitropropionic Acid-Induced Neurotoxicity in Experimental Animals.

    Rejuvenation research·2026

    Synaptic transmission and plasticity: molecular mechanisms, biological functions and therapeutic opportunities in neurodegenerative diseases.

    Signal transduction and targeted therapy·2026

    Third-Line Overactive Bladder Treatments: Cost-Benefit Analysis in an Australian Public Hospital.

    ANZ journal of surgery·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us